Literature DB >> 17011835

The effect of omitted covariates on confidence interval and study power in binary outcome analysis: a simulation study.

Abdissa Negassa1, James A Hanley.   

Abstract

BACKGROUND/
OBJECTIVES: The consequence of omitted but balanced covariates on odds ratio point estimation is well-known in the literature. When exposure or intervention has a non-null effect on disease outcome, omitted covariates lead to underestimation of the effect of exposure or intervention. However, the effect of omitted covariates on confidence interval and study power is unknown. STUDY DESIGN AND
SETTING: A simulation study is carried out to assess the effect of omitted covariates on confidence interval and study power for a plausible range of scenarios. Coverage probability and study power are assessed systematically over a range of study size, type of omitted covariate and magnitude of effect. A real-life example using a randomised experiment on flies' sexuality is provided.
RESULTS: When a balanced covariate is omitted, coverage probability was lowered by 2.9-80%. Likewise study power was reduced by as much as 58%. The impact becomes substantial when the covariate is continuous, has large variability and has a larger effect than the effect of exposure or intervention. The result from a real-life example concurs with the simulation finding.
CONCLUSION: Omitting an important balanced covariate lowers both coverage probability and study power. This implies the need for thoughtful consideration of important covariates at the design as well as the analysis stages of a study.

Mesh:

Year:  2006        PMID: 17011835     DOI: 10.1016/j.cct.2006.08.007

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  8 in total

1.  Overcoming underpowering: Trial simulations and a global rank end point to optimize clinical trials in children with heart disease.

Authors:  Kevin D Hill; H Scott Baldwin; David P Bichel; Alicia M Ellis; Eric M Graham; Christoph P Hornik; Jeffrey P Jacobs; Robert D B Jaquiss; Marshall L Jacobs; Prince J Kannankeril; Jennifer S Li; Rachel Torok; Joseph W Turek; Sean M O'Brien
Journal:  Am Heart J       Date:  2020-05-20       Impact factor: 4.749

Review 2.  Characteristics of effective collaborative care for treatment of depression: a systematic review and meta-regression of 74 randomised controlled trials.

Authors:  Peter A Coventry; Joanna L Hudson; Evangelos Kontopantelis; Janine Archer; David A Richards; Simon Gilbody; Karina Lovell; Chris Dickens; Linda Gask; Waquas Waheed; Peter Bower
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

Review 3.  Reporting on covariate adjustment in randomised controlled trials before and after revision of the 2001 CONSORT statement: a literature review.

Authors:  Ly-Mee Yu; An-Wen Chan; Sally Hopewell; Jonathan J Deeks; Douglas G Altman
Journal:  Trials       Date:  2010-05-18       Impact factor: 2.279

4.  Assessment and implication of prognostic imbalance in randomized controlled trials with a binary outcome--a simulation study.

Authors:  Rong Chu; Stephen D Walter; Gordon Guyatt; P J Devereaux; Michael Walsh; Kristian Thorlund; Lehana Thabane
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

5.  The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies.

Authors:  Brennan C Kahan; Vipul Jairath; Caroline J Doré; Tim P Morris
Journal:  Trials       Date:  2014-04-23       Impact factor: 2.279

6.  On tests of treatment-covariate interactions: An illustration of appropriate power and sample size calculations.

Authors:  Gwowen Shieh
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

7.  Adjusting for multiple prognostic factors in the analysis of randomised trials.

Authors:  Brennan C Kahan; Tim P Morris
Journal:  BMC Med Res Methodol       Date:  2013-07-31       Impact factor: 4.615

8.  Bayesian adaptive clinical trials of combination treatments.

Authors:  Kristian Thorlund; Shirin Golchi; Edward Mills
Journal:  Contemp Clin Trials Commun       Date:  2017-11-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.